C
Charles E. Murry
Researcher at University of Washington
Publications - 290
Citations - 46975
Charles E. Murry is an academic researcher from University of Washington. The author has contributed to research in topics: Induced pluripotent stem cell & Stem cell. The author has an hindex of 85, co-authored 270 publications receiving 43033 citations. Previous affiliations of Charles E. Murry include Duke University & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Setting global standards for stem cell research and clinical translation: The 2016 ISSCR guidelines
George Q. Daley,Insoo Hyun,Jane F. Apperley,Roger A. Barker,Nissim Benvenisty,Annelien L. Bredenoord,Christopher K. Breuer,Timothy Caulfield,Marcelle I. Cedars,Joyce Frey-Vasconcells,Helen E. Heslop,Ying Jin,Richard T. Lee,Christopher McCabe,Megan Munsie,Charles E. Murry,Steven Piantadosi,Mahendra Rao,Heather M. Rooke,Douglas Sipp,Lorenz Studer,Jeremy Sugarman,Masayo Takahashi,Mark W. Zimmerman,Jonathan Kimmelman +24 more
TL;DR: Key elements and recommendations in the guidelines are highlighted and summarized to provide confidence to practitioners and public alike that stem cell science can proceed efficiently and remain responsive to public and patient interests.
Journal ArticleDOI
VEGF Induces Differentiation of Functional Endothelium From Human Embryonic Stem Cells Implications for Tissue Engineering
Marilyn B. Nourse,Daniel E. Halpin,Marta Scatena,Derek J. Mortisen,Nathaniel L. Tulloch,Kip D. Hauch,Beverly Torok-Storb,Buddy D. Ratner,Lil Pabon,Charles E. Murry +9 more
TL;DR: The ability of hESC-derived endothelial cells to facilitate vascularization of tissue-engineered implants is demonstrated, and this enrichment method increases endothelial cell yield, enabling applications for revascularization as well as basic studies of human endothelial biology.
Journal ArticleDOI
Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms.
TL;DR: The evidence for potential mechanisms underlying the benefits of cell transplantation in the heart and the clinical contexts in which they may be relevant are reviewed.
Journal ArticleDOI
Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair : Effects on Cell Proliferation, Scar Contraction, and Ventricular Function
Jitka A. I. Virag,Marsha L. Rolle,Julia C. Reece,Sandrine N. Hardouin,Eric O. Feigl,Charles E. Murry +5 more
TL;DR: FGF2 is an important regulator of cell proliferation, angiogenesis, collagen synthesis, myocyte hypertrophy, scar contraction, and, ultimately, left ventricular contractile function during infarct repair and may be more important in healing ofinfarcts compared with skin wounds because of the mechanical stress under which infarCTs heal.
Journal ArticleDOI
Human Organ-Specific Endothelial Cell Heterogeneity.
Raluca Marcu,Yoon Jung Choi,Jun Xue,Chelsea L. Fortin,Yuliang Wang,Ryan J. Nagao,Jin Xu,James W. MacDonald,Theo K. Bammler,Charles E. Murry,Kimberly A. Muczynski,Kelly R. Stevens,Jonathan Himmelfarb,Stephen M. Schwartz,Ying Zheng +14 more
TL;DR: The link between human EC heterogeneity and organ development is shown and can be exploited therapeutically to contribute in organ regeneration, disease modeling, as well as guiding differentiation of tissue-specific ECs from human pluripotent stem cells.